共 113 条
[1]
Garcia de Tena J(2005)Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 353 429-430
[2]
Ridker PM(2000)C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 836-843
[3]
Hennekens CH(2013)Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives Curr Pharm Des 19 3827-3840
[4]
Buring JE(2006)Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target Curr Opin Pharmacol 6 154-161
[5]
Rifai N(2005)Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target Arterioscler Thromb Vasc Biol 25 923-931
[6]
Moutzouri E(2013)Lp-PLA2--a novel marker of atherosclerosis: to treat or not to treat? Int J Cardiol 165 213-216
[7]
Tsimihodimos V(2004)Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the atherosclerosis risk in communities (ARIC) study Circulation 109 837-842
[8]
Tselepis AD(2012)Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality Eur Heart J 33 2946-2954
[9]
Macphee CH(2014)Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the northern Manhattan study PLoS One 9 e83393-1711
[10]
Nelson J(2014)Darapladib for preventing ischemic events in stable coronary heart disease N Engl J Med 370 1702-1015